Monosaccharides

N-(Phenyl-1-propenyl)imino-2,3,4,6-tetra-O-pivaloyl-D-glucopyranoside (NPG) is a synthetic oligosaccharide. It is an Methylation and Click modification of the natural glycosylation product of glucose with pivalic acid. NPG has been shown to inhibit the Glycosylation enzyme by methylating it and preventing it to be able to catalyze the attachment of a sugar molecule to an amino acid residue. This inhibition prevents the production of complex carbohydrates in bacteria. NPG is also fluorinated at the 2,3,4,6 positions on the glucose ring which allows for better binding to bacterial cells. NPG has been shown to bind specifically to mycobacterial cell wall glycolipids and inhibit their synthesis as well as other bacterial cells such as staphylococcus aureus.

Ethyl 3,5,6-tri-O-benzyl-D-glucofuranoside is a modification of the natural carbohydrate D-glucose and has been synthesized by methylation. This product has a purity of 99% and is made up of three monosaccharides: D-glucose, D-mannose, and D-galactose. It also contains an oligosaccharide chain that consists of 6 sugar units. Ethyl 3,5,6-tri-O-benzyl-D-glucofuranoside is insoluble in water but soluble in acetone. The molecular weight of this product is 522.2 g/mol.

1,2,3-Tri-O-methyl-a-D-glucopyranose is a sugar that is used in glycosylation and fluorination reactions. This product can be custom synthesized to your specifications. It is available in high purity and with a variety of modifications. 1,2,3-tri-O-methyl-a-D-glucopyranose has been modified with methyl groups at the C1 and C6 positions. These modifications are useful for studies on glycosylation and fluorination reactions.

5-Azido-5,6-dideoxy-2,3-O-isopropylidene-D-gulonic acid-1,4-lactone is a carbohydrate that belongs to the group of saccharides. It is a synthetic sugar that has been modified with fluorine atoms on the 2 and 3 position of the sugar. 5-Azido-5,6-dideoxygulonic acid 1,4lactone has been shown to be resistant to enzymatic degradation by α amylase and β amylase. The compound also has a high level of purity (>98%) and custom synthesis capabilities.

(1R) -1- [(2S, 3R) - 3- Hydroxy- 1- methyl - 2- azetidinyl] -1, 2- ethanediol is a fluorinated sugar that is used in the synthesis of oligosaccharides and polysaccharides. This synthetic monosaccharide can be modified by glycosylation, methylation, and click chemistry. It has an CAS number and a high purity.

(3aS, 6aS) -Dihydro-2,2,6a-trimethyl-furo[3,4-d]-1,3-dioxol-4(3aH)-one is a white crystalline powder that is soluble in chloroform and ether. It can be used as a synthetic intermediate for the preparation of other products. It has been shown to be effective in methylation reactions on saccharides and polysaccharides. This product is available with custom synthesis options and can be modified with click chemistry or fluorination. This product is also available with high purity levels and fluorescence properties.

4-(4-(2-(trifluoromethyl)phenyl)-3-(E)-buten-2-one-1-yl)piperidine-2,6-dione is a custom synthesis that can be modified to include fluorination, methylation, and monosaccharide modifications. This molecule has been shown to have click modification and oligosaccharide modifications with saccharides. It is a polysaccharide that is glycosylated with carbohydrate.

Methyl 4-O-methyl-α-D-glucopyranoside is a methyl glucoside analogue

Methyl 3,4-di-O-acetyl-D-glucuronal is a sugar that has been synthesized in the laboratory. It is a functional sugar that can be used as a building block for other sugars. The conformation of this molecule was determined by conformational studies. This molecule has two benzyl groups that are oriented in different ways, which simplifies the parameters for this compound. Methyl 3,4-di-O-acetyl-D-glucuronal is an anomeric sugar and can be found in the pyranose ring. Methyl 3,4-di-O-acetyl-D-glucuronal also has a conformational theory that was developed to optimize its orientations and predict its geometries.

1,2,3,4-Tetra-O-acetyl-6,7-dideoxy-L-galacto-hept-6-enopyranose is a custom synthesis for the modification of saccharides. This compound has high purity and is synthesized by methylation of 1,2,3,4 tetra O acetyl 6,7 dideoxy L galacto hept 6 enopyranose with acetic anhydride and pyridine. The CAS number for this compound is 1193251-65-8.

Methyl 3,5-di-O-acetyl-2,4-anhydro-D-arabinonate is a custom synthesis of a complex carbohydrate. It is modified with methylation, glycosylation and click modification. This product has been fluorinated to provide high purity and is used in the preparation of other saccharides. Methyl 3,5-di-O-acetyl-2,4-anhydro-D-arabinonate belongs to the category of carbohydrates and sugars. This product is made up of a saccharide that contains three carbon atoms (C3H7O6) and one oxygen atom (O). The chemical formula for this compound is C3H5(COOC2H5)3.

D-myo-Inositol 1,4,6-triphosphate sodium salt (DMIPS) is an alkaline polymer. It is a high capacity, rechargeable electrode material that can be used in electrochemical cells. DMIPS has been shown to have the highest energy density and power density of any known polymer and can operate at low temperatures. This material has been shown to be effective in polymer electrolyte membrane fuel cells, as well as being used as a separator in lithium ion batteries.

5-O-tert-Butyldimethylsilyl-N-cyanomethyl-1,4-dideoxy-1,4-imino-2,3-O-isopropylidene--D ribitol is a fluorinated glycosylation product of 5-(O-(tertbutyldimethylsilyl)cyanomethyl)-1,4 dihydroxy imino 2,3 O isopropylidene D ribitol. It is a high purity complex carbohydrate that can be synthesized by click modification of 5-(O-(tertbutyldimethylsilyl)cyanomethyl)-1,4 dihydroxy imino 2,3 O isopropylidene D ribitol with ethynyltrifluoroborate and osmium tetroxide. This compound has CAS No. 577978-59-7.

Trehalose octaacetate is a carbohydrate that can be synthesized from trehalose and acetyl coenzyme A. It has been shown to act as an enzymatic substrate and a carbon source in the production of microparticles. Trehalose octaacetate is an antigenic molecule that can be used as a vaccine adjuvant to enhance the immune response to antigens. It also exhibits anti-inflammatory properties, which may be due to its ability to inhibit prostaglandin synthesis. Trehalose octaacetate is highly viscous, which makes it useful for the formulation of medications such as eye drops.

Methyl 2,3,4-tri-O-acetyl-6-O-triisopropylsilyl-a-D-glucopyranoside is a glycosylation product of D-glucose and methyl 2,3,4,6 triacetate. This product is a fluorinated sugar with the following chemical structure:

Calcium L-threonate is a four carbon monosaccharide

5-Keto-D-gluconic acid hemicalcium salt (5KDG) is an intermediate in the pentose phosphate pathway. It is a molecule that contains five carbon atoms, one double bond, and two hydroxyl groups. 5KDG has been found to be an effective inhibitor of gluconobacter, a type of bacteria which produces D-gluconic acid. The enzyme 5KDG dehydrogenase catalyzes the conversion of 5KDG into D-gluconate. 5KDG has been shown to have antiepileptic effects and can be used for the treatment of epilepsy.

L-Iduronic acid is a monosaccharide that is a component of the glycosaminoglycans. It is a sodium ion salt, which can be found in the extracellular matrix as part of the glycosaminoglycan heparan sulfate. Iduronic acid has been shown to have hypoglycemic effects in rats and mice and inhibitory properties against human osteosarcoma cells. L-Iduronic acid inhibits the synthesis of methyl glycosides by inhibiting the enzyme glucosyltransferase, which catalyzes the formation of glucuronoxylorxylan from glucose and xylose. The oligosaccharides are composed of iduronic acid units linked by α-1,4 linkages with β-1,4 linkages between adjacent iduronic acid units. The conformational properties of iduronic acid have been analyzed using X-ray crystallography and nuclear magnetic resonance spectroscopy (NMR

Dapagliflozin is a sodium-glucose cotransporter subtype 2 (SGLT2) inhibitor that can be used in the treatment of diabetes mellitus type 2. SGLT2 is located in the proximal convoluted tubule and when it is inhibited the reabsorption of glucose into the kidneys is prevented and instead glucose is excreted in the urine. As a result glucose levels are reduced. Dapagliflozin is metabolized into to its inactive metabolite 3-O-glucuronide by the UGT1A9 enzyme present in the liver and the kidneys. In addition, dapagliflozin has been shown to cause weight loss and decrease the risk of cardiovascular events such as congestive heart failure.